STERIS plc

NYSE:STE Stock Report

Market Cap: US$21.7b

STERIS Future Growth

Future criteria checks 1/6

STERIS is forecast to grow earnings and revenue by 11.3% and 5.9% per annum respectively. EPS is expected to grow by 11.5% per annum. Return on equity is forecast to be 11.6% in 3 years.

Key information

11.3%

Earnings growth rate

11.5%

EPS growth rate

Medical Equipment earnings growth13.2%
Revenue growth rate5.9%
Future return on equity11.6%
Analyst coverage

Good

Last updated24 Jan 2025

Recent future growth updates

Recent updates

STERIS plc (NYSE:STE) Shares Could Be 41% Below Their Intrinsic Value Estimate

Jan 19
STERIS plc (NYSE:STE) Shares Could Be 41% Below Their Intrinsic Value Estimate

STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Jan 01
STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

STERIS plc's (NYSE:STE) Popularity With Investors Is Clear

Dec 14
STERIS plc's (NYSE:STE) Popularity With Investors Is Clear

Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'

Nov 18

What Does STERIS plc's (NYSE:STE) Share Price Indicate?

Oct 19
What Does STERIS plc's (NYSE:STE) Share Price Indicate?

Is STERIS (NYSE:STE) A Risky Investment?

Oct 01
Is STERIS (NYSE:STE) A Risky Investment?

Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued

Sep 16

Earnings Tell The Story For STERIS plc (NYSE:STE)

Sep 13
Earnings Tell The Story For STERIS plc (NYSE:STE)

Steris: Q2 Numbers Solidify Buy Thesis

Aug 13

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price

Aug 08
STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price

When Should You Buy STERIS plc (NYSE:STE)?

Jul 04
When Should You Buy STERIS plc (NYSE:STE)?

Is STERIS (NYSE:STE) Using Too Much Debt?

Jun 13
Is STERIS (NYSE:STE) Using Too Much Debt?

Steris: Moving On, Losing Its Teeth

Apr 14

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

Mar 29
STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Mar 07
STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Steris: Strong Healthcare Products Growth Coupled With Weak AST Business

Feb 17

STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Feb 15
STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

Nov 08

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Sep 01

Steris: Continuing To Grow The Product Lineup

Jun 20

Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered

Feb 09

Steris declares $0.47 dividend

Feb 01

Steris declares $0.47 dividend

Nov 02

Steris: Non-GAAP Valuations Supportive Of Substantial Upside

Sep 04

Earnings and Revenue Growth Forecasts

NYSE:STE - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20276,1938541,2811,7076
3/31/20265,8317691,1061,3329
3/31/20255,4886607991,0999
9/30/20245,3265916801,101N/A
6/30/20245,235561594996N/A
3/31/20245,139551613973N/A
12/31/20234,7801,028594934N/A
9/30/20234,6011,012535849N/A
6/30/20234,563576494806N/A
3/31/20234,536557395757N/A
12/31/20224,784-28349713N/A
9/30/20224,777-8399752N/A
6/30/20224,773377472819N/A
3/31/20224,223285397685N/A
12/31/20214,248279412701N/A
9/30/20213,848250400662N/A
6/30/20213,407286424653N/A
3/31/20213,108397450690N/A
12/31/20203,057433476701N/A
9/30/20203,022424400627N/A
6/30/20203,003413384615N/A
3/31/20203,031408376591N/A
12/31/20192,976393340570N/A
9/30/20192,898336347573N/A
6/30/20192,840319336548N/A
3/31/20192,782304350540N/A
12/31/20182,730269325490N/A
9/30/20182,696316314467N/A
6/30/20182,651303N/A478N/A
3/31/20182,620291N/A458N/A
12/31/20172,585243N/A463N/A
9/30/20172,570144N/A453N/A
6/30/20172,582120N/A424N/A
3/31/20172,613110N/A424N/A
12/31/20162,616142N/A439N/A
9/30/20162,588167N/A364N/A
6/30/20162,431135N/A294N/A
3/31/20162,233111N/A255N/A
12/31/20152,04294N/A185N/A
9/30/20151,897113N/A221N/A
6/30/20151,870135N/A241N/A
3/31/20151,842135N/A246N/A
12/31/20141,807133N/A233N/A
9/30/20141,739123N/A234N/A
6/30/20141,660122N/A223N/A
3/31/20141,615129N/A210N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: STE's forecast earnings growth (11.3% per year) is above the savings rate (2.6%).

Earnings vs Market: STE's earnings (11.3% per year) are forecast to grow slower than the US market (15% per year).

High Growth Earnings: STE's earnings are forecast to grow, but not significantly.

Revenue vs Market: STE's revenue (5.9% per year) is forecast to grow slower than the US market (9% per year).

High Growth Revenue: STE's revenue (5.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: STE's Return on Equity is forecast to be low in 3 years time (11.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 22:58
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

STERIS plc is covered by 25 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel OwczarskiAvondale Partners
Michael PolarkBaird
Erin Wilson WrightBofA Global Research